Search research articles
Contact Us
Filters
Showing results (11-20 of 99) with videos related to
Page
of 10
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
November 22, 2005
[Targeted therapies in pediatric oncology: a new therapeutic approach?]
C Jubert, B Geoerger, J Grill, et al.
Journal of Neuro-Oncology
|
January 5, 2000
Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas
S Lescop, A Lellouch-Tubiana, G Vassal, et al.
Bone Marrow Transplantation
|
January 1, 1991
Autologous bone marrow transplantation in pediatric solid tumors: phase II studies
O Hartmann, G Vassal, D Valteau, et al.
Histopathology
|
May 1, 1995
Toxicity induced by chemotherapy mimicking cytomegalovirus gastritis
D Canioni, G Vassal, J Donadieu, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
October 1, 1995
[Pediatric aspects of anthracycline cardiotoxicity and practical implications for prevention]
F Pein, G Vassal, C Sakiroglu, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Pharmacokinetics of high-dose busulfan in children
G Vassal, A Gouyette, O Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2023
An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking
D Di Carlo, M Annereau, I Yoldjian, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
October 31, 2001
[Methotrexate-ciprofloxacin interaction: report of two cases of severe intoxication]
J H Dalle, A Auvrignon, G Vassal, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Enhanced cutaneous radiation effects following high-dose busulfan therapy
G Vassal, O Hartmann, J L Habrand, et al.
Pediatric Hematology and Oncology
|
January 1, 1990
Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma
G Vassal, D Valteau, M Bonnay, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 99) with videos related to
Sort By:
Page
of 10
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
November 22, 2005
[Targeted therapies in pediatric oncology: a new therapeutic approach?]
C Jubert, B Geoerger, J Grill, et al.
Journal of Neuro-Oncology
|
January 5, 2000
Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas
S Lescop, A Lellouch-Tubiana, G Vassal, et al.
Bone Marrow Transplantation
|
January 1, 1991
Autologous bone marrow transplantation in pediatric solid tumors: phase II studies
O Hartmann, G Vassal, D Valteau, et al.
Histopathology
|
May 1, 1995
Toxicity induced by chemotherapy mimicking cytomegalovirus gastritis
D Canioni, G Vassal, J Donadieu, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
October 1, 1995
[Pediatric aspects of anthracycline cardiotoxicity and practical implications for prevention]
F Pein, G Vassal, C Sakiroglu, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Pharmacokinetics of high-dose busulfan in children
G Vassal, A Gouyette, O Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2023
An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking
D Di Carlo, M Annereau, I Yoldjian, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
October 31, 2001
[Methotrexate-ciprofloxacin interaction: report of two cases of severe intoxication]
J H Dalle, A Auvrignon, G Vassal, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Enhanced cutaneous radiation effects following high-dose busulfan therapy
G Vassal, O Hartmann, J L Habrand, et al.
Pediatric Hematology and Oncology
|
January 1, 1990
Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma
G Vassal, D Valteau, M Bonnay, et al.
Page
of 10